152 related articles for article (PubMed ID: 2042390)
21. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
[TBL] [Abstract][Full Text] [Related]
22. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.
Hendry RM; Burns JC; Walsh EE; Graham BS; Wright PF; Hemming VG; Rodriguez WJ; Kim HW; Prince GA; McIntosh K
J Infect Dis; 1988 Apr; 157(4):640-7. PubMed ID: 3346563
[TBL] [Abstract][Full Text] [Related]
23. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
24. Comparison of class and subclass antibody response to live and UV-inactivated RSV administered intranasally in mice.
Reuman PD; Keely SP; Schiff GM
J Med Virol; 1991 Nov; 35(3):198-205. PubMed ID: 1804932
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
Murphy BR; Collins PL; Lawrence L; Zubak J; Chanock RM; Prince GA
J Gen Virol; 1989 Aug; 70 ( Pt 8)():2185-90. PubMed ID: 2671259
[TBL] [Abstract][Full Text] [Related]
26. Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV.
Murphy BR; Prince GA; Lawrence LA; Croen KD; Collins PL
Virus Res; 1990 Jun; 16(2):153-62. PubMed ID: 2385958
[TBL] [Abstract][Full Text] [Related]
27. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children.
Belshe RB; Anderson EL; Walsh EE
J Infect Dis; 1993 Oct; 168(4):1024-9. PubMed ID: 8376814
[TBL] [Abstract][Full Text] [Related]
29. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
30. Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity.
Oien NL; Brideau RJ; Thomsen DR; Homa FL; Wathen MW
Vaccine; 1993; 11(10):1040-8. PubMed ID: 8212825
[TBL] [Abstract][Full Text] [Related]
31. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.
Hsu KH; Lubeck MD; Davis AR; Bhat RA; Selling BH; Bhat BM; Mizutani S; Murphy BR; Collins PL; Chanock RM
J Infect Dis; 1992 Oct; 166(4):769-75. PubMed ID: 1527411
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats.
Prince GA; Capiau C; Deschamps M; Fabry L; Garçon N; Gheysen D; Prieels JP; Thiry G; Van Opstal O; Porter DD
J Virol; 2000 Nov; 74(22):10287-92. PubMed ID: 11044072
[TBL] [Abstract][Full Text] [Related]
35. Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens.
Buraphacheep W; Britt WJ; Sullender WM
J Clin Microbiol; 1997 Feb; 35(2):354-7. PubMed ID: 9003595
[TBL] [Abstract][Full Text] [Related]
36. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.
Prince GA; Horswood RL; Chanock RM
J Virol; 1985 Sep; 55(3):517-20. PubMed ID: 4020957
[TBL] [Abstract][Full Text] [Related]
37. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
[TBL] [Abstract][Full Text] [Related]
38. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
Trudel M; Stott EJ; Taylor G; Oth D; Mercier G; Nadon F; Séguin C; Simard C; Lacroix M
Arch Virol; 1991; 117(1-2):59-71. PubMed ID: 1706591
[TBL] [Abstract][Full Text] [Related]
39. The envelope proteins from purified respiratory syncytial virus protect mice from intranasal virus challenge.
Levine S; Dillman TR; Montgomery PC
Proc Soc Exp Biol Med; 1989 Apr; 190(4):349-56. PubMed ID: 2928348
[TBL] [Abstract][Full Text] [Related]
40. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
Bukreyev A; Yang L; Fricke J; Cheng L; Ward JM; Murphy BR; Collins PL
J Virol; 2008 Dec; 82(24):12191-204. PubMed ID: 18842713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
